Licitaciones Adjudicadas (36)
Tipo
|
Licitación
|
Adjudicación
|
---|---|---|
LP | 13-08-2020 | |
LP | 11-09-2020 | |
LQ | 03-12-2021 | |
LQ | 22-12-2023 | |
LE | 16-01-2024 | |
LE | 27-02-2024 | |
LE | 17-04-2023 | |
LE | 08-04-2024 | |
LE | 13-06-2023 | |
LE | 31-07-2023 | |
LE | 28-08-2023 | |
LE | 04-11-2021 | |
LE | 16-10-2023 | |
LE | 16-11-2023 | |
LQ | 29-04-2020 | |
LE | 10-08-2023 | |
LQ | 11-12-2019 | |
LQ | 14-08-2020 | |
LQ | 28-03-2024 | |
LE | 12-09-2022 | |
LE | 14-09-2020 | |
LE | 15-02-2024 | |
LQ | 14-12-2021 | |
LQ | 09-01-2023 | |
LP | 15-03-2022 | |
LE | 06-05-2021 | |
LQ | 30-08-2023 | |
LQ | 04-07-2022 | |
LE | 02-04-2020 | |
LQ | 08-03-2024 | |
LQ | 14-03-2023 | |
LP | 20-08-2020 | |
LQ | 05-03-2021 | |
LR | 18-06-2020 | |
LQ | 21-04-2021 | |
LQ | 06-07-2023 |
Rubros (8)
Producto
|
Total
|
Moneda
|
Licitaciones
|
---|---|---|---|
Antibióticos antineoplásticos | 2.602.083.600 | CLP | 1 |
Antimetabolitos | 169.950 | CLP | 1 |
Suplementos dietéticos y productos de terapia alimenticia | 10.561.800 | CLP | 3 |
Agentes de la esclerosis múltiple (EM) | 198.094.776 | CLP | 4 |
Agentes inmunoestimulantes | 103.374.718 | CLP | 2 |
Inmunodepresores | 32.656.844 | CLP | 2 |
Fármacos de tratamiento de la esclerosis lateral amiotrófica (ELA) | 570.393.985 | CLP | 14 |
Farmacéuticos | 480.141.384 | CLP | 9 |